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Abstract. Cadherins are calcium-dependent celladhe- 
sion molecules that play fundamental roles in embry- 
onic development, tissue morphogenesis, and cancer. A 
prerequisite for their function is association with the ac- 
tin cytoskeleton via the catenins. Tyrosine phosphory- 
lation of 13-catenin, which correlates with a reduction in 
cadherin-dependent cell adhesion, may provide cells 
with a mechanism toregulate cadherin activity. Here 
we report hat ~3-catenin immune precipitates from 
PC12 cells contain tyrosine phosphatase activity which 
dephosphorylates 13-catenin vitro. In addition, we 
show that a member of the leukocyte antigen-related 
protein (LAR)-related transmembrane tyrosine phos- 
phatase family (LAR-PTP) associates with the cad- 
herin-catenin complex. This association requires the 
amino-terminal domain of 13-catenin but does not re- 
quire the armadillo repeats, which mediate association 
with cadherins. The interaction also is detected inPC9 
cells, which lack a-catenin. Thus, the association is not 
mediated by a-catenin or by cadherins. Interestingly, 
LAR-PTPs are phosphorylated ontyrosine in a TrkA- 
dependent manner, and their association with the cad- 
herin--catenin complex is reduced in cells treated with 
NGF. We propose that changes in tyrosine phosphory- 
lation of ~3-catenin mediated by TrkA and LAR-PTPs 
control cadherin adhesive function during processes 
such as neurite outgrowth. 
C 
ADHERINS are calcium-dependent cell-cell adhe- 
sion molecules that are important regulators of 
morphogenesis (Takeichi, 1991). Their function 
requires association with the catenins, which link the highly 
conserved cadherin cytoplasmic domain to the actin-based 
cytoskeleton. 13-Catenin plays a key regulatory role in cad- 
herin function since it connects cadherins to ct-catenin, 
which is believed to bind the actin cytoskeleton directly 
(Rimm et al., 1995) or through a-actinin (Knudsen et al., 
1995). f~-Catenin also associates with the tumor-suppres- 
sor gene product (APC) adenomatous polyposis coli, and, 
together with the related protein, plakoglobin, and Arma- 
dillo (the Drosophila form of 13-catenin), is implicated in 
the Wnt/Wingless ignaling pathway, which determines 
the dorsoventral xis in Xenopus and segment polarity in 
Drosophila (for references see Hinck et al., 1994; Kirk- 
patrick and Peifer, 1995). 
Activation of several tyrosine kinases induces tyrosine 
phosphorylation f 13-catenin (Matsuyoshi et al., 1992; Beh- 
rens et al., 1993; Hamaguchi et al., 1993; Hoschuetsky et
al., 1994; Ochiai et al., 1994; Shibamoto et al., 1994). This 
phosphorylation correlates with perturbation of cadherin 
function in a number of cell types, as measured by de- 
creases in cell aggregation (Matsuyoshi et al., 1992; Ha- 
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maguchi et al., 1993), increases in cell migration (Hamagu- 
chi et al., 1993; Shibamoto et al., 1994), and loss of epithelial 
differentiation (Behrens et al., 1993). Inhibitors of tyrosine 
kinases block many of these physiological responses, while 
they are enhanced by an inhibitor of tyrosine phos- 
phatases, odium orthovanadate (Matsuyoshi et al., 1992; 
Hamaguchi et al., 1993). Furthermore, N-cadherin-depen- 
dent neurite outgrowth of neurons is blocked by vanadate 
(Bixby and Jhabvala, 1992; Kypta, R.M., unpublished ob- 
servations) and can be blocked or potentiated by tyrosine 
kinase inhibitors, depending on the cell type (Bixby and 
Jhabvala, 1992; Williams et al., 1994; Kypta, R.M., unpub- 
lished observations). Thus, a dynamic balance of phosphor- 
ylation and dephosphorylation of 13-catenin may regulate 
cadherin-dependent cell interactions. 
There are several ways in which phosphorylation f
~3-catenin might regulate cell function. For example, ty- 
rosine phosphorylation f 13-catenin may result in changes 
in the associations of components in the cadherin-catenin 
complex. Consistent with this possibility, transformation 
of epithelial cells by ras, which increases tyrosine phosphor- 
ylation of 13-catenin, results in dissociation of 13-catenin 
and cadherin, concomitant with stronger association of 
p120 Cas with cadherin (Kinch et al., 1995). Tyrosine 
phosphorylation f 13-catenin may also regulate its ability 
to signal; in Drosophila, Wingless negatively regulates Ar- 
madillo phosphorylation serine and tyrosine residues 
(Peifer et al., 1994). An understanding of the pathways 
that lead to dephosphorylation of 13-catenin may help us 
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distinguish the possible functions of 13-catenin tyrosine 
phosphorylation. 
In this paper, we show that [3-catenin is subject o rapid 
dephosphorylation, both in vitro and in vivo. We have in- 
vestigated the mechanism for this dephosphorylation and 
found that the cadherin-catenin complex is associated 
with a member of the leukocyte common antigen-related 
protein (LAR) 1 subfamily of transmembrane tyrosine 
phosphatases (LAR-PTP). There are three known LAR- 
PTPs (LAR [Streuli et al., 1988], PTP8 [Krueger et al., 
1990; Mizuno et al., 1993], and PTP-P1 (Pan et al., 1993), 
also known as PTP NE-3, RPTPg, CRYPot, and LAR-2 
[Walton et al., 1993; Yan et al., 1993; Stoker, 1994; Zhang 
et al., 1994]), all of which have extracellular domains con- 
sisting of immunoglobulin-like domains and fibronectin 
type III domains, and at least two of which are expressed 
in PC12 cells. Our data suggest potential mechanisms by 
which cadherin-dependent processes might be regulated 
by tyrosine dephosphorylation. 
Materials and Methods 
Cell Culture, Labeling, and Transfection 
The PC12 cell line expressing human trk, PC12 6-24 (from Dr. D. Kaplan, 
MeGill University, Montreal, Quebec) was grown according to Hemp- 
stead et al. (1992). Cells were incubated for 16 h in low-serum medium 
(LSM: 10% normal growth medium in DME) in the presence or absence 
of 30 ng/ml NGF (from Dr. W. Mobley) before lysis and immune precipi- 
tation, For Fig. 2 a, cells were incubated for 4 h in methionine and cys- 
teine-fi'ee growth medium containing dialyzed serum and 1 mCi/ml Trans- 
label (ICN Biomedicals, Inc., Costa Mesa, CA). PC12 cells were grown on 
collagen (Vitrogen, Celtrix Labs, Palo Alto, CA), in DME containing 
t0% horse serum and 5% FCS. PC9 cells (kindly provided by M. Takei- 
chi, Kyoto University, Japan) were grown in a 1:1 mixture of DME and 
Ham's F12 supplemented with 10% FCS. 
COS cells were grown in DME containing 10% FCS. Transient trans- 
fections were done in Optimem 1 using Lipofectamine (GIBCO BRL, 
Gaithersburg, MD) according to manufacturers protocols. Cells were 
transfected in serum-free medium for 6 h and then grown for 16 h in Opti- 
mere 1 with 10% FCS, followed by 8-10 h in DME with 10% FCS and fi- 
nally t8-24 h in DME with 1% FCS. 
Antibodies 
Antibodies recognizing 13-catenin were generated as follows: Xenopus 
l$-catenin eDNA (McCrea et al., 1991) (from Drs. P. McCrea, MD Ander- 
son Cancer Center, Houston, TX, and B. Gumbiner, Sloan-Kettering Can- 
eer Center, New York) was expressed in Sf9 cells using a baculovirus ex- 
pression system (CIontech, Palo Alto, CA) and purified on NTA-agarose 
(Oiage~ Inc., Chatsworth, CA) by means of six carboxyl-terminal histi- 
dine residues generated by PCR. (PCR-generated fragments were either 
sequenced or replaced by sequences from the original [3-catenin clone.) 
Purified protein was injected into rabbits for production of antisera 
(CALTAG, San Francisco, CA). Anti-a-catenin antibodies were gener- 
ated in rabbits using as immunogen the peptide CSQKKHISPVQALSE- 
FKAMDSF, corresponding to the carboxyl-terminat residues of chicken 
aN-catenin, coupled to maleimide-activated keyhole limpet hemocyanin 
(KLH; Pierce, Rockford, IL). Anti-4i-end antibodies were raised in rab- 
bits ~sing as immunogen the peptide CYQAALEYLGSFDHYAT cou- 
to KLH. The control antibody used was raised in rabbits against he 
¢x~atra] peptide (CDQYKFCYEVALEYLNSG) coupled to KLH. Mono- 
clonal antibodies to human LAR and receptor protein tyrosine phos- 
phatase RPTP5 were kindly provided by Dr. M. Streuli (Dana-Farber 
L Abbrevi~ions used in this paper: LAR, leukocyte antigen-related protein; 
LAR-P'I~, member of the LAR subfamily of transmembrane tyrosine phos- 
phatases; LB, lysis buffer; RP'I~, receptor protein tyrosine phosphatase. 
Cancer Institute, Boston, MA). Antibodies used for Western blotting are 
commercially available (see below). 
DNA Plasmid Constructs 
The 13-catenin constructs were generated as follows: The coding region of 
Xenopus 13-catenin eDNA (McCrea et al., 1991) was amplified by PCR to 
include a sequence ncoding a myc-epitope tag (EQKLISEEDL) at the 
carboxyl-terminus. The PCR-generated construct was ligated into pCRII 
and the ends were sequenced. Amplified DNA that was not sequenced 
was replaced by subcloning of unamplified fragments from the original 
[3-catenin clone. An Nsil fragment encoding the myc-tagged 13-catenin 
(13myc) was subcloned into the PstI site of the COS cell expression vector 
pMT23 (from Dr. Gordon Wong, Genetics Institute, Cambridge, MA). 
13ANmyc was generated by deleting the sequences upstream of the unique 
Xhol site, thereby encoding a protein beginning at methionine 174 of 
13myc. 13ACmyc omprises residues 1-698 of 13-catenin with a myc tag. It 
was generated by deletion mutagenesis u ing the Transformer Mutagene- 
sis Kit (Clontech, Palo Alto, CA) and a mutagenic oligonucleotide that re- 
moved the sequences encoding residues 699-781. 13ANACmyc encodes 
residues 173-698 of 13-catenin with a myc tag and was generated by delet- 
ing the sequences upstream of the unique XhoI site in 13ACmyc. 13ARmyc 
was generated by deleting the sequences between the unique Xhol and 
XbaI sites in 13myc. It encodes a protein containing residues 1-151 fused 
to residues 648-781 followed by the myc-epitope tag. Rat TrkA eDNA 
(kindly provided by Dr. D. Clary, SUGEN, Redwood City, CA) was also 
subcloned into pMT23 in sense and antisense orientations. Human LAR 
(Streuli et al., 1988) and RPTP8 (Pulido et al., 1995a) eDNA expression 
vectors were kindly provided by Dr. M. Streuli. 
Cell Lysis and Immune Precipitation 
All reagents were from Sigma Chemical Co. (St. Louis, MO) unless peci- 
fied. Sodium orthovanadate was prepared as described (Brown and Gor- 
don, 1984) and added to 0.1 mM at 37°C. Before lysis, cells (~2 × 10 -6 per 
10-cm plate) were washed once in PBS, except for experiments involving 
phosphatase assays, where they were washed in Tris-buffered saline (TBS: 
50 mM Tris-Cl, pH 7.5, 150 mM NaC1) with 0.1 mM DTI r. Cell lysis was 
for 10 min on ice in 1 ml lysis buffer (LB: 20 mM Tris-Cl, pH 8.0. 150 mM 
NaC1, 50 mM NaF, 10 mg/ml aprotinin, 10 mg/ml eupeptin, 1mM EDTA, 
1% NP-40, 1 mM sodium molybdate, and 0.1 mM sodium orthovanadate). 
For experiments where the association between LAR-PTPs and the cad- 
herin--catenin complex was being studied, LB contained 10 mM DTT 
and 0.1 mg/ml 4-(2-aminoethyl)-benzene-sulfonyl fluoride hydrochlorine 
(AEBSF) (ICN Biomedicals, Inc.). For experiments in PC12 6-24 cells 
where tyrosine phosphorylation was being studied, LB did not contain 
DTT. Octylglucoside lysis buffer was LB containing 40 mM octylglucoside 
instead of NP-40. For experiments where LAR and RPTP8 tyrosine phos- 
phorylation were studied in COS cells, cell lysis was in a modified RIPA 
buffer (LB containing 1% Triton X-100, 0.5% deoxycholate, and 0.1% 
SDS instead of NP-40, plus 5 mM sodium pyrophosphate, 1 mM molyb- 
date, and 0.5 mM vanadate). Cell lysates were scraped on ice and clarified 
at 15,000 g for 12 min at 4°C. For Fig. 2 a, cell extracts were precleared us- 
ing protein A-Sepharose (Pharmacia LKB Biotechnology, Inc., Uppsala, 
Sweden). Depletion experiments were performed by incubating PCI2 cell 
extracts for 2 h with antibodies bound to protein A-Sepharose (protein 
A-Sepharose was incubated for 16 h in the presence of 50 p.l of antiserum 
and washed three times with lysis buffer before use) and then for an addi- 
tional 30 min with unbound beads. The control antibody used for these ex- 
periments was raised to an unrelated peptide. Immune precipitates were 
prepared at 4°C by incubating with 8 ~1 antiserum for i h, followed by in- 
cubation for 30 min at 4°C on a rotator with protein A-Sepharose. Im- 
mune complexes were washed four times in lysis buffer and once in TBS 
containing 0.1 mM vanadate. 
Phosphatase Assays 
Cells were washed and lysed using LB without molybdate and vanadate, 
but with 10 mM DTI'. Immune complexes were washed four times in LB 
and once in phosphatase buffer (20 mM Tris-Cl, pH 6.8, 10 mM DTT). 
Phosphatase assays were conducted in 50 p.l phosphatase buffer with or 
without 0.1 mM vanadate and 0.1 mM phosphopeptide DADEpYLIPQQG 
(Promega Corp., Madison, Wl). The serine-phosphorylated p ptide used 
in some control experiments was GENPIYKpSAVITVVNPKYEGK, a 
The Journal of Cell Biology, Volume 134, 1996 1520 
sequence which corresponds tothe cytoplasmic tail of integrin 131 subunit 
(a gift from D.Y. Wu, University of California, San Francisco, CA). For 
peptide dephosphorylation, immune complexes were prepared using 200 
~,g extract, and phosphate released was measured using malachite green 
according to manufacturers in tructions (Promega Corp.). Reactions were 
approximately linear over the time assayed. Control immune precipitates 
were done using preimmune serum, rabbit IgG, or antisera ised to unre- 
lated peptides, and all gave similar esults. 
Western Blotting 
Washed immune complexes were h ated to 100°C for 5 rain in reducing 
SDS sample buffer, separated on 6% polyacrylamide g ls, and transferred 
to nitrocellulose (BA83; Schleicher & Schuell, Inc., Keene, NH) using a 
semi-dry apparatus (Millipore Corp., Bedford, MA). Membranes were 
rinsed in 10 mM Tris-Cl, pH 7.5, 100 mM NaCl, 0.1% Tween-20 (TBS-T) 
and incubated in blocking buffer (TBS-T with 3% BSA, 1% ovalbumin) 
for 1 h. Primary antibodies were diluted in blocking buffer and incubated 
with membranes for 2-16 h. Anti~5-end antibodies w re used at 1:100, a 
rat monoclonat ntibody to a-catenin (et-18 from Drs. A. Nagafuchi and 
S. Tsukita [Nagafuchi and Tsukita, 1994]) at 1:20, 13-catenin monoclonal 
antibody (Transduction Laboratories, Lexington, KY) at 1:1,000, pan-cad- 
herin polyclonal and monoclonal ntibodies (Sigma Chemical Co.) at 1:500, 
anti-myc epitope tag monoclonal antibody (9E10; Santa Cruz Biotech. 
Inc., Santa Cruz, CA) at 1:1,000, and HRP-conjugated antiphosphoty- 
rosine antibody RC20H (Transduction Laboratories) at t:2,000. Mem- 
branes were washed in TBS-T and probed with either HRP-conjugated 
(GIBCO BRL) or alkaline phosphatase-coniugated (Promega Corp.) sec- 
ondary antibodies according to manufacturers in tructions. Blots were de- 
veloped using chemiluminescence for HRP-conjugated antibodies (ECL; 
Amersham Corp., Arlington Heights, IL), or using 160 ~g/ml 4-nitro blue 
tetrazolium chloride (NBT) and 80 p.g/ml 5-bromo-4-chtoro-3-indolyl- 
phosphate (BCIP) in 100 mM NaC1, 5 mM MgC12, 100 mM Tris, pH 9.5, 
for alkaline phosphatase-coniugated ntibodies. Where indicated in the 
figure legends, blots were stripped by incubation at 65°C in 62.5 mM Tris- 
CI, pH 6.8, 0.1 M 13-mercaptoethanol, 2% SDS for l0 min, followed by 
washing overnight with several changes of TBS-T before reprobing. 
Results 
fl-Catenin Immune Precipitates Contain Tyrosine 
Phosphatase Activity 
In experiments directed towards understanding the regu- 
lation of N-cadherin function in neurons, we have been 
studying tyrosine phosphorylation f 13-catenin PC12 6-24 
cells. Since these cells overexpress human TrkA, NGF 
treatment results in enhanced and prolonged phosphoryla- 
tion of intracellular proteins (Hempstead et al., 1992). To 
our surprise, we observed a similar level of 13-catenin ty- 
rosine phosphorylation i PC12 6-24 cells and normal 
PC12 cells (Kypta, R.M., unpublished observations), sug- 
gesting that a tyrosine phosphatase (PTP) acting preferen- 
tially on [3-catenin may compensate for the increase in 
TrkA activity. 
Figure 1. Phosphotyrosine phosphatase activity associated with 
13-catenin. (a) Anti-phosphotyrosine (upper panel) or anti-13- 
catenin (lower panel) Western blots of 13-catenin mmune precipi- 
tates from equal amounts of extracts of PC12 6--24 cells either 
untreated (lane 1), treated with 50 ng/ml NGF for 5 min (lane 2), 
treated with 0.1 mM sodium orthovanadate for 30 rain (lane 3), 
treated with 50 ng/m! NGF for 16 h (lane 4), or treated with NGF 
for 16 h and sodium orthovanadate for the final 30 rain (lane 5). 
For the result shown in the lower panel, the blot in the upper 
panel was stripped and reprobed with anti-tB-catenin antibodies. 
The lines on the left of each panel indicate the positions of molec- 
ular mass markers (100.6 kD and 71.6 kD). (b) Anti-phosphoty- 
rosine (upper panel) or anti-13-catenin (lower panel) Western 
blots IB-catenin immune precipitates from equal amounts of ex- 
tracts of cells treated with NGF for 16 h and sodium orthovana- 
date for the final 30 min and lysed in the absence ot vanadate. 
Washed immune precipitates were incubated in phosphatase 
buffer with vanadate (lane 1) or without vanadate (lane 2). For 
the result shown in the lower panel, the blot in the upper panel 
was stripped and reprobed with anti-13-catenin antibodies. The 
band below [3-catenin in the upper panel was observed also in 
control immune precipitates. The residual signal in lane 2 is  simi- 
lar to that seen for purified unphosphorytated [3-catenin. (c) 
Phosphatase activity in control antibody or 13-catenin immune 
precipitates as measured using a phosphotyrosyl peptide sub- 
strate. In this experiment, 60 pmol of phosphate corresponded to
100 U (an OD of 0.1 at 620 nm after addition of malachite green 
reagent). 
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To investigate the possible role of a tyrosine phos- 
phatase, we examined the effects on [3-catenin phosphory- 
lation of the tyrosine phosphatase inhibitor, sodium ortho- 
vanadate (Brown and Gordon, 1984). In the absence of 
vanadate, addition of NGF to PC12 6-24 cells for 10 min 
(Fig. 1 a, lane 2) or 16 h (lane 3) increased tyrosine phos- 
phorylation of [3-catenin. Interestingly, addition of vana- 
date to PC12 6-24 cells also increased tyrosine phosphory- 
lation of 13-catenin, even in the absence of NGF (lane 4). 
[3-Catenin phosphorylation was dependent on TrkA activity 
since the effects of vanadate were blocked by the TrkA in- 
hibitor Tyrphostin AG879 and by K252a (data not shown). 
The latter is a relatively broad specificity kinase inhibitor 
that nonetheless inhibits purified TrkA in vitro and blocks 
the effects of NGF (but not FGF) on PC12 cells in vivo 
(Berg et al., 1992; Nye et al., 1992; Tapley et al., 1992; 
Ohmichi et al., 1993). Addition of vanadate to PC12 6-24 
cells that had been treated with NGF for 16 h resulted in 
dramatically elevated phosphorylation f 13-catenin (lane 
5). Increased tyrosine phosphorylation f 13-catenin after 
addition of vanadate also was observed using ~-catenin 
immune precipitates and was detected in another cell line 
which expresses human TrkA (PC12 6-15 cells; Hemp- 
stead et al., 1992) (data not shown). The changes in [3-cate- 
nin tyrosine phosphorylation were not due to changes in 
[3-catenin levels, as shown by reprobing the blot with anti- 
13-catenin antibodies (Fig. 1 a, lower panel). 
The increased phosphorylation of 13-catenin in cells 
treated with NGF or vanadate and the inhibition of this 
phosphorylation byinhibitors of TrkA suggest that [3-cate- 
nin phosphorylation is tightly regulated by the activities of 
TrkA and a tyrosine phosphatase. To test the possibility 
that [3-catenin is associated with a tyrosine phosphatase, 
immune precipitates containing tyrosine-phosphorylated 
13-catenin were prepared from extracts of PC12 6-24 ceils 
that had been treated with NGF and vanadate (which was 
removed before lysis). Washed immune precipitates were 
incubated at 30°C either with or without vanadate and 
then analyzed by anti-phosphotyrosine W stern blotting. 
The results in Fig. 1 b show that the amount of phosphoty- 
rosine on 13-catenin was reduced by incubation in the ab- 
sence of vanadate (lane 2), relative to in the presence of 
vanadate (lane 1). Reprobing the blot demonstrated the 
amount of 13-catenin was unchanged (lower panel). There- 
fore, this 13-catenin immune precipitate contained tyrosine 
phosphatase activity which dephosphorylated [3-catenin i  
vitro. 
To examine the phosphatase activity in [3-catenin im- 
mune precipitates further, phosphatase assays were con- 
ducted using an exogenous tyrosine-phosphorylated p p- 
tide substrate (Fig. 1 c). [3-Catenin immune precipitates 
from PC12 6-24 cells contained significant phosphatase 
activity when compared to control immune precipitates. 
The phosphatase activity did not dephosphorylate a serine- 
phosphorylated peptide (data not shown), suggesting it
was specific for phosphotyrosine. 
The Cadherin-Catenin Complex Associates 
with LAR-related Phosphatases 
We sought o identify the tyrosine phosphatase associated 
with the cadherin-catenin complex. There are several can- 
didates that could play this role: the SH2-containing pro- 
tein tyrosine phosphatases SHP-1 and SHP-2, both of 
which are expressed in PC12 cells (Vambutas et al., 1995), 
are cytoplasmic phosphatases that bind tyrosine-phosphor- 
ylated proteins. SHP-1 is activated by NGF treatment 
(Vambutas et al., 1995); RPTPtx is a transmembrane ty- 
rosine phosphatase that shares weak sequence homology 
with cadherins (Tonks et al., 1992) and appears to associ- 
ate directly with cadherins (Brady-Kalnay et al., 1995); fi- 
nally, at least wo members of the LAR subfamily of trans- 
membrane tyrosine phosphatases are expressed in PC12 
cells, and their mRNA levels are increased in NGF-treated 
PC12 cells (Pan et al., 1993; Zhang and Longo, 1995). 
We were unable to detect association between SHP-1 or 
SHP-2 with the cadherin-catenin complex, and RPTPIx is 
not expressed in PC12 cells (Kypta, R.M., unpublished ob- 
servations; Gebbink et al., 1995). To examine the possibil- 
ity that LAR-PTPs mediate dephosphorylation f [3-cate- 
nin, we prepared an antibody (called 8-end) to a peptide 
corresponding to the common carboxyl-terminal t il of the 
LAR subfamily of PTPs. b-end immune precipitates from 
radiolabeled PC12 6-24 cell extracts contained at least 
four specific proteins, with apparent molecular masses of 
approximately 150, 105, 95, and 80 kD (Fig. 2 a, lane 2). 
These proteins were not present when the antiserum was 
incubated with cell extracts in the presence of the b-end 
peptide (lane 1). In other experiments, the 150- and 80-kD 
proteins could further be resolved into multiple bands, and 
the 80-kD proteins were recognized inWestern blots using 
the b-end antiserum (data not shown). These results are 
consistent with previous tudies using antibodies to LAR 
and PTPb, which have shown that the mature forms of 
these phosphatases consist of a 150-kD extracellular f ag- 
ment (E subunit) and a noncovalently associated 85-kD 
fragment (P subunit) containing extracellular, transmem- 
brane, and cytoplasmic sequences (Streuli et al., 1992; Yu 
et al., 1992; Pulido et al., 1995a). For convenience, the 
LAR subfamily proteins recognized by the antibody b-end 
will be called LAR-PTPs in this paper. Interestingly, the 
two additional major radiolabeled proteins pecifically im- 
mune precipitated by b-end antibodies (Fig. 2 a, lane 2) 
comigrated with [3- and ~-catenins (Fig. 2 a, lanes 4 and 6, 
respectively), suggesting that they might be LAR-PTP- 
associated catenins. 
To provide stronger evidence for association of LAR- 
PTPs and catenins, b-end immune precipitates were probed 
with antibodies to components of the cadherin-catenin 
complex. The results demonstrated the presence of c~-cate- 
nin (Fig. 2 b, lane 2), cadherin (Fig. 3), and [3-catenin (Fig. 
4). Results of an anti--~-catenin Western blot (Fig. 2 b) 
show that c~-catenin was detected in b-end immune precip- 
itates prepared in the presence of an irrelevant control 
peptide (lane 2) but not in g-end immune precipitates pre- 
pared in the presence of the immunogen, the g-end pep- 
tide (lane 1). In addition, control immune precipitates 
(lanes 3 and 4) did not contain a-catenin, and the presence 
of a-catenin in anti--a-catenin mmune precipitates was 
not affected by incubation with either b-end (lane 5) or 
control (lane 6) peptides. 
Comparison of the relative amounts of cadherin de- 
tected in c~-catenin and b-end immune precipitates (Fig. 3 a) 
suggested that the amount of cadherin associated with 
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Figure 2. Association of 
the cadherin-catenin com- 
plex with LAR-related pro- 
teins. (a) Immune precipi- 
tates from equal amounts 
of [35S]methionine/cysteine- 
labeled PC12 6-24 cell ex- 
tracts were visualized by au- 
toradiography: Anti-g-end in 
the presence of ~-end peptide 
(lane 1), anti-g-end (lane 2), 
anti-13-catenin in the presence 
of purified t3-catenin (lane 3), 
anti-13-catenin (lane 4), anti-a-catenin i  the presence of cognate peptide (lane 5), and anti-a-catenin (lane 6). The lines without arrows 
on the right indicate the positions of molecular mass markers (100.6 kD and 71.6 kD). The positions of proteins pecifically immune- 
precipitated by anti~5-end antibodies are indicated by the arrows on the left. The fastest migrating band corresponds to LAR-PTP P 
subunits. The positions of a-catenin (lane 6), 13-catenin (lane 4), and the LAR-PTP P subunit (lane 2) were confirmed bytransfer of ra- 
diolabeled immune precipitates to nitrocellulose and subsequent Western blotting. In lane 3, immune precipitation using anti-13-catenin 
antibodies in the presence of purified unlabeled 13-catenin blocked association of the antibody with labeled 13-catenin but not with c~-cate- 
nin, probably because a-catenin bound to the purified 13-catenin i the immune precipitate. (b) The following immune precipitates from 
equal amounts of cell extracts were probed with anti-~-catenin a tibody: Anti-g-end in the presence of either g-end peptide (lane 1) or 
control peptide (lane 2), anti--control peptide in the presence of either g-end peptide (lane 3) or control peptide (lane 4), and anti--a-cate- 
nin in the presence of either ~-end peptide (lane 5) or control peptide (lane 6). The lines on the left indicate the positions of molecular 
mass markers (208 kD, 100.6 kD, and 71.6 kD). 
Figure 3. Association of LAR-PTPs with cadherin. (a) The fol- 
lowing immune precipitates from equal amounts of cell extract 
were probed with anti-pan cadherin antibody: Control anti-pep- 
tide antibody (lane 1), anti-8-end (lane 2), anti--a-catenin (lanes 3 
and 4; lane 3 contained 20 times more immune precipitate than 
lane 4). Lane 5 contains cell extract. The lines on the left indicate 
the positions of molecular mass markers (208 kD, 100.6 kD, and 
71.6 kD). (b) Cell extracts depleted using the following antibod- 
ies were loaded in equal amounts (except where indicated) and 
probed using anti-pan cadherin antibodies: Control anti-peptide 
antibody (lane 1), anti-g-end (lanes 4 and 5), and anti--a-catenin 
(lanes 6 and 7). Lanes 2, 3, and 8 contained 90%, 80%, and 20%, 
respectively, of the amount of extract loaded in lane 1. The lines 
on the left indicate the positions of molecular mass markers (208 
kD, 100.6 kD, and 71.6 kD). 
c~-catenin (lane 3) was about 10 times that associated with 
LAR-PTPs (lane 2). For comparison, lane 4 contains 20 
times less a-catenin immune precipitate than lane 2. To 
determine the fraction of total cadherin associated with 
LAR-PTPs, we depleted PC12 cell extracts using either 
control, e~-catenin, or g-end antibodies, and measured the 
amount of cadherin remaining (Fig. 3 b). The results from 
duplicate experiments were quantitated by densitometry 
and comparison with known amounts of cell extracts that 
had been incubated with control antibodies. While a-cate- 
nin antibodies depleted over 80% of cadherin (lanes 6 and 
7), g-end antibodies depleted 8%. Therefore, about 10% 
of cadherin-catenin complexes in PC12 cells are associ- 
ated with LAR-PTPs. 
Octylglucoside, but not NP-40, has been shown to selec- 
tively dissociate c~-catenin from the cadherin-catenin com- 
plex (Ozawa and Kemler, 1992). We compared the associ- 
ation of LAR-PTPs with catenins after lysis in buffers 
containing either NP-40 or octylglucoside (Fig. 4). Cell ex- 
tracts prepared in NP-40 lysis buffer (lane 7) and octylglu- 
coside lysis buffer (lane 8) contained similar amounts of 
a-catenin (Fig. 4, upper panel, lanes 7 and 8), ~-catenin 
(lower panel, lanes 7 and 8), and LAR-PTPs (data not 
shown). As anticipated, preparation of PC12 cell extracts 
in octylglucoside, but not NP-40, disrupted association of 
a-catenin with cadherin (upper panel, lanes 3 and 4) and 
[3-catenin (lanes 5 and 6). Interestingly, the association of 
LAR-PTPs with ~-catenin was also disrupted after lysis in 
octylglucoside but not NP-40 (upper panel, lanes 1 and 2). 
Reprobing the membranes with anti-[3-catenin a tibodies 
(Fig. 4, lower panel) indicated that, while octylglucoside 
did not affect the association between [3-catenin and cad- 
herins (lanes 3 and 4), it disrupted the association between 
13-catenin and LAR-PTPs (lanes 1 and 2). Since octylglu- 
coside disrupts the association of LAR-PTPs with both 
~-catenin and [3-catenin, this experiment does not demon- 
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Figure 4. LAR-PTPs dissociate from the cadherin- 
catenin complex in octylglucoside. Anti--a-catenin 
(upper panel) and anti-13-catenin (lower panel) 
Western blots of immune precipitates (lanes 1--6) or 
extracts (lanes 7 and 8) from PC12 6-24 cells tysed 
either in NP-40-containing lysis buffer (n, lanes 1, 3, 
5, and 7) or lysis buffer containing 40 mM octylgtu- 
coside (o, lanes 2, 4 6, and 8). Immune precipitates 
from equal amounts of cell extract were prepared 
using anti--45-end (lanes 1 and 2), anti-pan-cadherin 
(lanes 3 and 4) and anti-13-catenin (lanes 5 and 6) 
antibodies. The lines on the left of each panel indi- 
cate the positions of molecular mass markers (100.6 
kD and 71.6 kD). There is a residual signal of 
0t-catenin in the blot shown in the lower panel be- 
cause the blot in the upper panel was reprobed with- 
out stripping. 
strate which protein in the cadherin-catenin complex me- 
diates the interaction of this complex with LAR-PTPs. 
The Amino-terminal Domain of ~Catenin Is Required 
for Association of the Cadherin-Catenin Complex with 
LAR-PTPs 
To determine which component of the cadherin--c.atenin 
complex mediates the interaction with LAR-PTPs, we 
constructed a number of myc-epitope-tagged 13-catenin 
deletion mutants and expressed them transiently in COS 
cells (Fig. 5). The upper panel of Fig. 5 is an anti-myc 
(9El0) Western blot of whole cell extracts containing 
these constructs. We previously observed that LAR-PTPs 
associate with the cadherin-catenin complex in some fi- 
broblast cell lines, including COS cells, although to a lesser 
extent than in PC12 cells (Kypta, R.M., data not shown). 
Therefore, ~-end immune precipitates were prepared from 
COS cell extracts that contained 13-catenin deletion mu- 
tants and then probed with antibodies that recognize the 
myc-epitope tag (Fig. 5, lower panel). As expected, full- 
length, myc-epitope-tagged t3-catenin (t3) associated with 
both LAR-PTPs (lower panel, lane 1) and a-catenin (data 
not shown). Deletion of the amino-terminal domain (/iN, 
lane 2) but not the carboxyl-terminal domain (zaC, lane 3) 
of 13-catenin prevented association of 13-catenin with both 
LAR-PTPs (lower panel) and with a-catenin (data not 
shown). Interestingly, a 13-catenin mutant lacking the ar- 
madillo repeat region (AR)st i l l  associated with LAR- 
PTPs (lower panel, lane 5). 
Since cadherins associate with the armadillo repeat re- 
gion of 13-catenin, these results indicate that, in contrast o 
RPTPv,, LAR-PTPs do not interact directly with cad- 
herins. However, these experiments do not address 
whether the amino-terminal domain of 13-catenin directly 
binds LAR-PTPs or if the association ismediated by a-cate- 
nin (or an unknown protein). To determine the impor- 
tance of ct-catenin to the association between LAR-PTPs 
and the cadherin-catenin complex, we prepared extracts 
from PC9 cells (Fig. 6). PC9 cells do not express et-catenin, 
but do express 13-catenin and cadherins (Hirano et al., 
1992). As expected, anti--a-catenin antibodies coimmune 
precipitated 13-catenin from extracts of PC12 cells (lane 2), 
but not from extracts of PC9 cells (lane 5). Interestingly, 
13-catenin was found in ~i-end immune precipitates from 
both PC12 cells (lane 3) and PC9 cells (lane 6). 
To summarize, these results indicate that LAR-PTPs as- 
sociate with the cadherin--catenin complex through an in- 
teraction with the amino-terminal domain of 13-catenin 
and that 13-catenin does not have to associate with cad- 
herins or a-catenin to mediate this interaction. 
Figure 5. The amino-terminal domain of 13-catenin is required for 
association of LAR-PTPs with the cadherin-catenin complex. 
Anti-myc lag (9El0) Western blots of extracts (upper panel) and 
anti-,5-end immune precipitates (lower panel) from extracts of 
COS cells transfected with the indicated 13-catenin expression 
constructs./3, full-length myc-tagged [3-eatenin (lane 1);/IN, resi- 
dues 174-781 {lane 2); /tC, residues 1-698 (lane 3); ANAC, resi- 
dues 174-698 (lane 4); AR, residues 1-151 fused to residues 648- 
781 (lane 5), or cells transfected with empty vector (lane 6). The 
arrows indicate the positions of fl (lane 1), AC (lane 3), and AR 
(lane 5). The lines on the left of each panel indicate the positions 
of molecular mass markers (100.6 kD, 71.6 kD, and 43.5 kD). The 
bands running above the position of the bottom arrow are IgG 
heavy chain, which cross-reacts with the secondary antibody: 
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Figure 6. The association between LAR-PTPs and the cadherin- 
catenin complex does not require a-catenin. Anti-13-catenin 
Western blot of immune precipitates from PC12 cells (lanes 1-3) 
or PC9 cells (lanes 4-45). Antibodies used for immune precipita- 
tion were anti-[3-catenin (lanes 1 and 4), anti--~-catenin (lanes 2 
and 5), and anti-g-end (lanes 3 and 6). The lines on the left of 
each panel indicate the positions of molecular mass markers 
(100.6 kD and 71.6 kD). 
TrkA-dependent Tyrosine Phosphorylation 
of LAR-PTPs 
Tyrosine phosphorylation of 13-catenin might be expected 
to alter its interaction either with LAR-PTPs, cadherin, or 
other catenins. However, we have not observed such 
changes after vanadate treatment of PC12 6-24 cells (data 
not shown). As another possibility, activation of TrkA 
may result in changes in LAR-PTP catalytic activity, per- 
haps by tyrosine phosphorylation of the latter. We there- 
fore examined the possibility that LAR-PTPs are tyrosine 
phosphorylated. Results in Fig. 7 show that addition f 
vanadate to NGF-treated PC12 6-24 ceils increased ty- 
rosine phosphorylation of the P subunit of LAR-PTPs 
(lane 4) and 13-catenin (lane 2). This phosphorylation was 
blocked by the TrkA inhibitors K252a and tyrphostin 
AG879 (data not shown), suggesting that TrkA activation 
is necessary for tyrosine phosphorylation of LAR-PTPs. 
We were unable to detect changes in LAR-PTP tyrosine 
phosphorylation or catalytic activity after addition of NGF 
alone (Kypta, R.M., unpublished observations), perhaps 
because LAR-PTPs are rapidly dephosphorylated in the 
absence of tyrosine phosphatase inhibitors. It thus remains 
possible that LAR-PTP activity is regulated by tyrosine 
phosphorylation, but that this was not detectable using in 
vitro assays. 
To determine whether TrkA induces tyrosine phosphor- 
ylation of LAR-PTPs without the addition of vanadate to 
living cells, LAR-PTPs were coexpressed with TrkA in 
COS cells (Fig. 7 b). COS cells were transfected with cDNAs 
expressing human LAR (lanes 1 and 2) and human RPTPb 
(lanes 3 and 4) together with plasmids containing rat TrkA 
eDNA (lanes 2 and 4) or TrkA eDNA cloned in the anti- 
sense orientation as a control (lanes 1 and 3). LAR and 
RPTP~ immune precipitates from transfected COS cell ex- 
tracts were probed sequentially with antibodies to anti- 
phosphotyrosine (upper panel) and ~-end antibodies 
(lower panel). Expression of TrkA induced tyrosine phos- 
phorylation of both LAR (upper panel, lane 2) and RPTP~ 
(lane 4). Therefore, LAR-PTPs can be tyrosine-phosphor- 
Figure 7. TrkA induces ty- 
rosine phosphorylation of 
LAR-PTPs. (a) Tyrosine 
phosphorylation of LAR- 
PTPs in PC12 6--24 cells. 
Western blots of immune 
precipitates from equal 
amounts of cell extracts of 
NGF-treated cells that were 
either untreated (lanes 1 and 
3) or treated with vanadate 
(lanes 2 and 4) before lysis, 
prepared using anti-13-catenin 
(lanes 1 and 2) or anti-g-end 
(lanes 3 and 4) antibodies, 
were probed with anti-phos- 
photyrosine antibodies (up- 
per panel) or anti-g-end anti- 
bodies (lower panel). The 
positions of LAR-PTP P sub- 
units and 13-catenin are indi- 
cated. The lines on the left of 
each panel indicate the posi- 
tions of molecular mass markers (upper panel: 100.6 kD and 71.6 kD; lower panel: 208 kD, 100.6 kD, and 71.6 kD). Tyrosine-phosphory- 
lated 13-catenin is detectable in g-end immune precipitates (upper panel, lane 4). Vanadate does not alter the amount of LAR-PTPs 
(lower panel, compare lanes 3 and 4). (b) TrkA expression i  COS cells induces tyrosine phosphorylation f LAR and RPTPS. Anti- 
phosphotyrosine (upper panel) and anti-g-end (lower panel) Western blots of anti-LAR (lanes 1 and 2) or anti-RPTP~ (lanes 3 and 4) 
immune precipitates from equal amounts of cell extracts of COS cells transfected with vectors expressing LAR eDNA (lanes 1 and 2), 
RPTP8 eDNA (lanes 3 and 4), control DNA (lanes I and 3), or TrkA eDNA (lanes 2 and 4). In each panel, the arrows mark the posi- 
tions of uncleared LAR-PTP P+E subunits (top arrows) and cleaved LAR-PTP P subunits (bottom arrows). The lines on the right of 
each panel indicate the positions of molecular mass markers (208 kD, 100.6 kD, and 71.6 kD). The additional band recognized by anti- 
g-end antibodies (lower panel, lanes 3 and 4) may be a breakdown product of RPTPS, since it was observed only in COS cells trans- 
fected with RPTP8 eDNA. 
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Figure 8. Regulation of the LAR-PTP- 
cadherin-catenin complex by NGF. (a) 
NGF increases cellular levels of LAR- 
PTPs. Western blots of extracts (lanes 1--6) 
or g-end immune precipitates (lanes 7 
and8) from untreated PC12 6-24 cells 
(lanes 1, 3, 5, and 7) or PC12 6--24 cells 
treated with NGF for 16 h (lanes 2, 4, 6, 
and 8) were probed with anti-pan cadherin 
(lanes 1 and 2), anti-a-catenin (lanes 3 
and 4), anti-t3-catenin (lanes 5 and 6), and 
anti-g-end (lanes 7 and 8) antibodies. The 
lines on the right of lanes 1~5 and on the 
left of lanes 7 and 8 indicate the positions 
of molecular mass markers (208 kD, 100.6 
kD, and 71.6 kD). These blots were devel- 
oped using a colorimetric assay. (b) NGF 
treatment results in downregulation f the 
LAR-PTP-cadherin-catenin complex. 
Western blots of immune precipitates 
from equal amounts of cell extracts of un- 
treated cells (lanes 1, 3, 5, and 8) or cells 
treated with NGF for 16 h (lanes 2, 4, 6, 
and 7) using anti-a-catenin (lanes 1 and 
2), anti-[?,-catenin (lanes 3 and 4), and 
anti-g-end (lanes 5~) antibodies were 
probed with anti-[3-catenin monoclonal 
antibody (lanes 1~5) or both anti-[3-cate- 
nin and anti-g-end antibodies (lanes 7 and 
8, developed using a colorimetric assay). 
The lines on the left of the panel indicate 
the positions of molecular mass markers 
(100.6 kD and 71.6 kD). 
ylated in a TrkA-dependent manner both in PC12 6-24 
cells and in COS cells. 
Downregulation of the LAR-PTP-Cadherin-Catenin 
Complex by NGF 
Addition of NGF to PC12 cells has been shown to increase 
the levels of N-cadherin, LAR, and PTP-P1 mRNAs 
(Doherty et al., 1991; Pan et al., 1993; Zhang and Longo, 
1995). We compared the relative amounts of components 
of the LAR-PTP-cadherin-catenin complex in PC12 6-24 
cells either untreated or treated with NGF for 16 h (Fig. 8 a). 
Relative to their levels in untreated PC12 6-24 cells (lanes 
1, 3, and 5), treatment of PC12 6-24 cells with NGF did not 
change the levels of cadherin (lanes 1 and 2), a-catenin 
(lanes 3 and 4), or 13-catenin (lanes 5 and 6). In contrast, a
small increase in the level of LAR-PTPs was seen after ad- 
dition of NGF to PC12 6-24 cells (lanes 7 and 8), consis- 
tent with the NGF-induced increases in mRNA levels de- 
scribed for PTP-P1 and LAR (Pan et al., 1993; Zhang and 
Longo, 1995). 
We next compared the relative amounts of LAR-PTP-  
cadherin-catenin complexes in untreated and NGF-treated 
PC12 6-24 cells (Fig. 8 b). While NGF treatment of PC12 
6-24 cells did not detectably alter the amount of 13-catenin 
associated with a-catenin (lanes 1 and 2) or with cadherin 
(data not shown), Western blotting of ~-end immune pre- 
cipitates showed that the amount of 13-catenin associated 
with LAR-PTPs decreased about twofold after NGF treat- 
ment (lanes 5 and 6). This change is best observed when 
the same ~-end immune precipitates are probed with both 
anti-[3-catenin and ~-end antibodies (lanes 7 and 8). 
Therefore, although the levels of LAR-PTPs increase in 
NGF-treated PC12 6-24 cells, there is a decrease in the 
relative amount of associated [3-catenin. 
To summarize the data presented in Figs. 7 and 8, LAR-  
PTPs have the potential to be regulated by NGF in the 
short term by t rosine phosphorylation, and in the long 
term by increases in protein levels. In addition, LAR-PTP 
interactions with the cadherin-catenin complex are also 
regulated, as documented by the reduction in their associ- 
ation observed in NGF-treated cells. 
Discussion 
The results from a number of studies have suggested that 
13-catenin tyrosine phosphorylation plays a dynamic role in 
processes such as cell aggregation (Matsuyoshi et al., 1992; 
Hamaguchi et al., 1993), cell migration (Hamaguchi et al., 
1993; Shibamoto et al., 1994), and epithelial differentiation 
(Behrens et al., 1993). Rapid regulation of these events re- 
quires that phosphorylation be tightly controlled by ty- 
rosine kinases and phosphatases. Indeed, receptor tyro- 
sine kinases associate with ~-catenin in some cell lines 
(Hoschuetsky et al., 1994; Ochiai et al., 1994), but not in 
others (Matsuyoshi et al., 1992; Hamaguchi et al., 1993; 
Behrens et al., 1993; Shibamoto et al., 1994). We have ex- 
amined phosphorylation/dephosphorylation mechanisms 
of 13-catenin i  PC12 cells and have found that 13-catenin is
associated with a tyrosine phosphatase. This phosphatase 
is capable of dephosphorylating 13-catenin itself in vitro. 
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The rapid increase of [3-catenin tyrosine phosphorylation 
in vanadate-treated PC12 6--24 cells strongly suggests that 
this association also occurs in vivo. 
The association of the major components of the cad- 
herin-catenin complex was not detectably altered after 
vanadate-induced tyrosine phosphorylation of [3-catenin 
(data not shown), as was observed by others using v-src- 
transformed cells (Behrens et al., 1993). However, trans- 
formation of epithelial cells by ras, which increases ty- 
rosine phosphorylation f [3-catenin, results in dissociation 
of [3-catenin and cadherin (Kinch et al., 1995). Therefore, 
there may be cell-type specific differences in the regula- 
tion of cadherin--catenin interactions by tyrosine phosphor- 
ylation. These might be determined by phosphorylation f 
specific tyrosine residues on [3-catenin or by phosphoryla- 
tion of other proteins. 
One possible result of increased tyrosine phosphoryla- 
tion of [3-catenin is a reduction in cadherin-dependent cell
aggregation. We have been unable to test this possibility in 
PC12 cells, since they aggregate poorly (Kypta, R.M., un- 
published observations). Recently, expression of v-src in 
fibroblasts lacking [3-catenin was shown to shift cell adhe- 
sion mediated by a cadherin--a-catenin fusion protein from 
a strong to a weak state, suggesting that tyrosine phosphor- 
ylation of [3-catenin is not required for this shift (Takeda 
et al., 1995). Since cadherin-dependent cellaggregation i
these fibroblasts i  the same in the presence or absence of 
v-src, tyrosine phosphorylation f [3-catenin may regulate 
cadherin function of cells already in the weak state of cell 
adhesion, such as PC12 cells, during processes such as neu- 
rite outgrowth. 
Recently Brady-Kalnay et al. (1995) reported that cad- 
herins associate with the transmembrane tyrosine phos- 
phatase RPTP~ in a mink lung epithelial cell line. While 
our experiments do not address the possibility that the 
cadherin--catenin complex associates with tyrosine phos- 
phatases in addition to LAR-PTPs in PC12 cells, the activ- 
ity measured in [3-catenin immune precipitates cannot in- 
clude RPTPI~ since this protein is not expressed in PC12 
cells (Kypta, R.M., unpublished observations; Gebbink et al., 
1995). The RPTP~-related protein, RPTPK (Jiang et al., 
t993), is expressed at low levels in PC12 cells (Kypta, 
R.M., unpublished observations). Therefore, it remains 
possible that the cadherin--catenin complex in PC12 cells 
also associates with RPTPK. 
There are a number of further differences between the 
cadherin-catenin complexes that associate with LAR-PTPs 
and RPTPI~. RPTPIx localizes to cell junctions. In contrast 
LAR-PTPs are not concentrated in cell junctions of PC12 
cells (data not shown) or MCF-7 cells (Serra-Pages et al., 
1995); and, while RPTPp. associates directly with cad- 
herins, the association between LAR-PTPs and the cad- 
herin-catenin complex is mediated by the amino-terminal 
domain of 13-catenin. 
The importance of the amino-terminal domain of 13-cate- 
nin for the association of LAR-PTPs with the cadherin- 
catenin complex is intriguing. While several proteins interact 
with the armadillo repeat region of [3-catenin (Kirkpatrick 
and Peifer, 1995), only e~-catenin has been shown to associ- 
ate with the amino-terminal domain of 13-catenin, and the 
binding site for a-catenin overlaps with the beginning of 
the armadillo repeat region (Aberle et al., 1996). Onco- 
genic forms of 13-catenin deleted in the amino-terminal do- 
main have been found (Oyama et al., 1994; Kawanishi et al., 
1995; Whitehead et al., 1995). The inability of one of these 
mutants to bind et-catenin results in reduced cell adhesion, 
which can be rescued by expression of full-length 13-cate- 
nin (Kawanishi et al., 1995). It has been suggested that 
such mutations in 13-catenin may be involved in the en- 
hancement of tumor invasion in human cancers (Oyama et 
al., 1994). Since these mutant forms of [3-catenin probably 
no longer associate with LAR-PTPs, it is also possible that 
disruption of the cadherin-catenin-LAR-PTP complex plays 
a role in cell transformation. Consistent with this possibil- 
ity, human LAR (Streuli et al., 1992) and murine RPTP8 
(Mizuno et al., 1993) map to chromosomal regions that 
contain candidate tumor suppressor genes. 
The high sequence homology among LAR-PTPs sug- 
gests that all three members associate with the cadherin- 
catenin complex. Indeed, LAR-PTPs are known to inter- 
act with a common cytoplasmic protein, LIP.1 (Pulido et al., 
1995b). To date, we have been unable to demonstrate a di- 
rect association between the cytoplasmic domain of the rat 
LAR-PTP PTP-P1 (Pan et al., 1993) and [3-catenin using gel 
overlay assays (Kypta, R.M., unpublished observations), 
so the interaction may be mediated by another protein. 
Alternatively, posttranslational modifications of 13-catenin 
or a particular isoform of PTP-P1 may be required for as- 
sociation. 
The effects of vanadate on tyrosine phosphorylation f 
LAR-PTPs in PC12 6-24 cells suggest that LAR-PTPs are 
rapidly phosphorylated and dephosphorylated in vivo. Ex- 
pression of TrkA induced tyrosine phosphorylation f LAR 
and RPTP~ in COS cells without he addition of vanadate 
before cell lysis. Interestingly, tyrosine phosphorylation f 
LAR and RPTP8 in COS cells was on their full-length, un- 
cleaved forms, rather than the cleaved P subunits of LAR- 
PTPs that were phosphorylated in vanadate-treated PC12 
6-24 ceils. This may reflect the ratios of uncleaved to 
cleaved forms of LAR-PTPs in COS and PC12 cells. An 
intriguing possibility is that cleavage of LAR-PTPs leads 
to their activation, with PC12 cells containing a higher pro- 
portion of cleaved, activated LAR-PTPs, whose phosphor- 
ylation is only detectable using vanadate. 
Assessment of the effects of tyrosine phosphorylation 
on LAR-PTP activity is hampered by the fact that stable 
phosphorylation requires the presence of vanadate, which 
inhibits LAR-PTPs. An understanding of the conse- 
quences of this phosphorylation LAR-PTP activity will 
require the identification and mutation of the TrkA- 
induced tyrosine phosphorylation sites. There is precedent 
for regulation of PTPs by tyrosine phosphorylation: the 
nonreceptor phosphatase, PTP1C, is phosphorylated on 
tyrosine in response to insulin receptor activation, and this 
correlates with an increase in its activity (Uchida et al., 
1994); RPTPa is phosphorylated constitutively on tyrosine 
(den Hertog et al., 1994; Suet al., 1994), and in vitro ex- 
periments uggest hat tyrosine phosphorylation reduces 
the activity of this phosphatase (den Hertog et al., 1994). 
Therefore, TrkA-induced phosphorylation f LAR-PTPs 
provides apotential mechanism for regulating their activi- 
ties. 
Addition of NGF to PC12 6-24 cells reduces the associa- 
tion between LAR-PTPs and the cadherin-catenin corn- 
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plex, suggesting that TrkA activity somehow regulates this 
association. Consistent with this possibility is the observa- 
tion that tyrosine phosphatase activity in 13-catenin im- 
mune precipitates from parental PC12 cells, which express 
far less TrkA than PC12 6--24 cells, is higher than that in 
PC12 6-24 cells (Kypta, R.M., unpublished observations). 
It is unclear whether the reduced association seen after 
NGF treatment reflects astoichiometric change in binding 
or a weakened association that leads to disruption of the 
complex during cell lysis and immune precipitation. An al- 
ternative xplanation for the reduced association i NGF- 
treated cells is that the cadherin-catenin complex associates 
with a modified form of LAR-PTPs, such as one containing 
a differentially spliced exon. This is an exciting possibility, 
since isoforms of LAR, RPTP~, and RPTP~r do contain 
additional cytoplasmic residues encoded by such exons 
(Pulido et al., 1995b), which, at least in LAR, become 
downregulated after NGF treatment of PC12 cells (Zhang 
and Longo, 1995). 
Recently DLAR, a Drosophila LAR-PTP expressed in 
developing neurons, was shown to play a key role during 
motor neuron growth cone guidance (Krueger et al., 1996). 
Although all neurons express DLAR, only a subset of 
neurons make axon-pathfinding errors in Dlar mutant em- 
bryos. While this observation may reflect he restricted lo- 
calization of the putative ligand for DLAR, it may also de- 
lineate specific cadherin-dependent guidance pathways. 
N-cadherin--dependent neurite outgrowth is affected by 
inhibition of tyrosine phosphorylation (Bixby and Jhab- 
vala, 1992; Williams et al., 1994). In addition, neurite out- 
growth of PC12 cells growing on purified N-cadherin re- 
quires NGF and is blocked both by TrkA inhibitors and 
vanadate (Kypta, R.M., unpublished observations), sug- 
gesting that it requires tyrosine kinase and phosphatase 
activities. Our immunocytochemical experiments (Kypta, 
R.M., unpublished observations) indicate that LAR-PTPs 
and cadherins/catenins partially colocalize in neurites, fur- 
ther suggesting a role for the complex in neurite out- 
growth. Indeed, the chicken LAR-PTP, CRYP-a, which is 
expressed within both the lamellipodia nd filopodia of 
neuronal growth cones, has been proposed to regulate 
growth cone migration (Stoker et al., 1995). 
The LAR-PTP-cadherin-catenin complex is most abun- 
dant in PC12 cells but is also present in fibroblasts, sug- 
gesting that it may also have a more general function. 
We propose that cycles of 13-catenin tyrosine phosphoryla- 
tion and dephosphorylation provide a mechanism rapidly 
to regulate cell-cell interactions, which may be required 
for cadherin-dependent functions that include neurite out- 
growth (Bixby et al., 1988; Matsunaga et al., 1988; Toma- 
selli et al., 1988; Bixby and Jhabvala, 1990) and cell motility 
(Hamaguchi et al., 1993; Nagafuchi et al., 1994; Shibamoto 
et al., 1994). An alternative function for the LAR-PTP- 
cadherin-catenin complex might be to regulate the signal- 
ing function of 13-catenin. For example, LAR-PTPs may be 
involved in transducing Wnt signals. 
There are three, not mutually exclusive ways in which such 
mechanisms might operate. First, catenins could serve as a 
link between LAR-PTPs and the actin-based cytoskeleton. 
This would provide a mechanism to stabilize potential ad- 
hesive interactions mediated by the extracellular domains 
of LAR-PTPs. Second, coclustering of cadherins and 
LAR-PTPs may result in activation of LAR-PTPs. This 
would maintain 13-catenin i  the dephosphorylated state, 
which may be a prerequisite for cadherin-dependent cell
adhesion (Matsuyoshi et al., 1992; Behrens et al., 1993; 
Hamaguchi et al., 1993). Third, association of 13-catenin 
with LAR-PTPs could allow a rapid reversal of growth 
factor-induced tyrosine phosphorylation f 13-catenin. Ex- 
tracellular signals transduced by binding of putative ligands 
to LAR-PTPs would then provide additional pathways to 
modulate cadherin function. 
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